Edwards Lifesciences Corp (EW)vsSmith & Nephew SNATS Inc (SNN)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
SNN
Smith & Nephew SNATS Inc
$32.45
+0.90%
HEALTHCARE · Cap: $13.65B
Smart Verdict
WallStSmart Research — data-driven comparison
Smith & Nephew SNATS Inc generates 2% more annual revenue ($6.16B vs $6.07B). EW leads profitability with a 17.7% profit margin vs 10.1%. SNN appears more attractively valued with a PEG of 0.66. SNN earns a higher WallStSmart Score of 62/100 (C+).
EW
Buy55
out of 100
Grade: C
SNN
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Margin of Safety
+47.3%
Fair Value
$66.92
Current Price
$32.45
$34.47 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Earnings expanding 70.4% YoY
Growing faster than its price suggests
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : SNN
The strongest argument for SNN centers on EPS Growth, PEG Ratio. PEG of 0.66 suggests the stock is reasonably priced for its growth.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : SNN
No major red flags identified for SNN, but monitor valuation.
Key Dynamics to Monitor
EW profiles as a mature stock while SNN is a value play — different risk/reward profiles.
EW carries more volatility with a beta of 0.93 — expect wider price swings.
EW is growing revenue faster at 13.3% — sustainability is the question.
SNN generates stronger free cash flow (595M), providing more financial flexibility.
Bottom Line
SNN scores higher overall (62/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Smith & Nephew SNATS Inc
HEALTHCARE · MEDICAL DEVICES · USA
Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?